HEADER APOPTOSIS INHIBITOR 27-APR-07 2PON TITLE SOLUTION STRUCTURE OF THE BCL-XL/BECLIN-1 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: BECLIN-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: COILED-COIL MYOSIN-LIKE BCL2-INTERACTING PROTEIN; PROTEIN COMPND 5 GT197; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: APOPTOSIS REGULATOR BCL-X; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: DELETION OF 45-84; COMPND 11 SYNONYM: BCL-2-LIKE 1 PROTEIN; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BECN1, GT197; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET32A; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: BCL2L1, BCL2L, BCLX; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET32A KEYWDS APOPTOSIS; AUTOPHAGY; BCL-2 FAMILY PROTEINS; BECLIN-1, APOPTOSIS KEYWDS 2 INHIBITOR EXPDTA SOLUTION NMR NUMMDL 20 MDLTYP MINIMIZED AVERAGE AUTHOR W.FENG,S.HUANG,H.WU,M.ZHANG REVDAT 3 16-MAR-22 2PON 1 REMARK REVDAT 2 24-FEB-09 2PON 1 VERSN REVDAT 1 04-SEP-07 2PON 0 JRNL AUTH W.FENG,S.HUANG,H.WU,M.ZHANG JRNL TITL MOLECULAR BASIS OF BCL-XL'S TARGET RECOGNITION VERSATILITY JRNL TITL 2 REVEALED BY THE STRUCTURE OF BCL-XL IN COMPLEX WITH THE BH3 JRNL TITL 3 DOMAIN OF BECLIN-1. JRNL REF J.MOL.BIOL. V. 372 223 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17659302 JRNL DOI 10.1016/J.JMB.2007.06.069 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1, CNS 1.1 REMARK 3 AUTHORS : BRUNGER, A.T. (CNS), BRUNGER, A.T. (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PON COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042611. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50MM POTASSIUM PHOSPHATE REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.5MM UNLABELLED BCL-XL/BECLIN-1 REMARK 210 COMPLEX IN 99.9% D2O; 50MM REMARK 210 POTASSIUM PHOSPHATE; 1.5MM REMARK 210 UNIFORMLY 15N LABELLED BCL-XL/ REMARK 210 BECLIN-1 COMPLEX IN 90% H2O/10% REMARK 210 D2O; 50MM POTASSIUM PHOSPHATE; REMARK 210 1.5MM UNIFORMLY 15N/13C LABELLED REMARK 210 BCL-XL/BECLIN-1 COMPLEX IN 99.9% REMARK 210 D2O; 50MM POTASSIUM PHOSPHATE; REMARK 210 1.5MM 80% DEUTERATED, UNIFORMLY REMARK 210 15N/13C LABELLED BCL-XL/BECLIN-1 REMARK 210 COMPLEX IN 90% H2O/10% D2O; 50MM REMARK 210 POTASSIUM PHOSPHATE; 1.5MM 100% REMARK 210 DEUTERATED, UNIFORMLY 15N REMARK 210 LABELLED BCL-XL/BECLIN-1 COMPLEX REMARK 210 IN 90% H2O/10% D2O; 50MM REMARK 210 POTASSIUM PHOSPHATE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; 3D_13C- REMARK 210 SEPARATED_NOESY; HNCO, HNCA, REMARK 210 HN(CO)CA, HNCACB AND CBCA(CO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 18 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 23 -53.47 -125.17 REMARK 500 1 ASP A 39 -80.18 -126.52 REMARK 500 1 ILE A 40 161.55 58.82 REMARK 500 1 MET A 41 -71.70 -95.13 REMARK 500 1 SER B 58 107.20 61.76 REMARK 500 1 GLN B 59 -46.53 -130.76 REMARK 500 1 SER B 60 70.22 -155.23 REMARK 500 1 PHE B 83 42.46 -155.92 REMARK 500 1 ASP B 85 -21.94 74.46 REMARK 500 1 VAL B 86 20.03 47.43 REMARK 500 1 GLU B 88 -74.76 -177.94 REMARK 500 1 ASN B 89 123.33 173.00 REMARK 500 1 THR B 91 -64.49 -138.44 REMARK 500 1 GLU B 92 128.25 60.80 REMARK 500 1 PRO B 94 -74.97 -64.49 REMARK 500 1 ALA B 120 -64.50 -99.05 REMARK 500 1 SER B 122 175.67 52.85 REMARK 500 1 ASP B 123 -177.29 -53.92 REMARK 500 1 SER B 126 54.38 -97.47 REMARK 500 1 GLN B 127 -53.32 -165.01 REMARK 500 1 LEU B 128 -172.41 -59.85 REMARK 500 1 HIS B 129 92.68 -165.74 REMARK 500 1 THR B 134 13.71 -142.73 REMARK 500 1 ASN B 152 158.75 169.18 REMARK 500 1 LYS B 173 -70.27 -78.80 REMARK 500 1 GLU B 174 43.35 168.16 REMARK 500 2 ILE A 40 159.13 60.11 REMARK 500 2 MET A 41 -45.78 -142.15 REMARK 500 2 SER B 58 87.48 60.82 REMARK 500 2 GLN B 59 -68.17 -109.04 REMARK 500 2 SER B 60 63.77 -171.54 REMARK 500 2 PHE B 83 37.77 -143.49 REMARK 500 2 GLU B 88 -50.91 178.43 REMARK 500 2 ASN B 89 153.82 68.25 REMARK 500 2 PRO B 94 -70.68 -65.03 REMARK 500 2 GLU B 95 146.38 -177.04 REMARK 500 2 PHE B 121 -75.39 -123.89 REMARK 500 2 SER B 122 171.74 175.31 REMARK 500 2 SER B 126 36.30 -97.16 REMARK 500 2 GLN B 127 22.03 -148.23 REMARK 500 2 HIS B 129 109.82 -169.15 REMARK 500 2 PRO B 132 80.82 -56.64 REMARK 500 2 ASN B 152 160.92 161.85 REMARK 500 2 LYS B 173 -71.21 -79.39 REMARK 500 2 GLU B 174 42.67 168.82 REMARK 500 3 THR A 23 -67.99 68.72 REMARK 500 3 ASP A 39 -71.06 -96.30 REMARK 500 3 ILE A 40 157.21 60.16 REMARK 500 3 MET A 41 -31.35 -137.79 REMARK 500 3 SER B 58 87.72 60.32 REMARK 500 REMARK 500 THIS ENTRY HAS 399 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2PON A 21 43 UNP Q14457 BCN1_HUMAN 1 23 DBREF 2PON B 57 100 UNP Q07817 BCLX_HUMAN 1 44 DBREF 2PON B 101 212 UNP Q07817 BCLX_HUMAN 85 196 SEQRES 1 A 23 GLY GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS VAL SEQRES 2 A 23 THR GLY ASP LEU PHE ASP ILE MET SER GLY SEQRES 1 B 156 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 B 156 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 B 156 PHE SER ASP VAL GLU GLU ASN ARG THR GLU ALA PRO GLU SEQRES 4 B 156 GLY THR GLU SER GLU ALA VAL LYS GLN ALA LEU ARG GLU SEQRES 5 B 156 ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SEQRES 6 B 156 SER ASP LEU THR SER GLN LEU HIS ILE THR PRO GLY THR SEQRES 7 B 156 ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU LEU PHE SEQRES 8 B 156 ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SEQRES 9 B 156 SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL ASP LYS SEQRES 10 B 156 GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA TRP MET SEQRES 11 B 156 ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN SEQRES 12 B 156 GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU TYR GLY HELIX 1 1 THR A 23 PHE A 38 1 16 HELIX 2 2 SER B 60 GLY B 77 1 18 HELIX 3 3 SER B 84 GLU B 88 5 5 HELIX 4 4 THR B 97 PHE B 121 1 25 HELIX 5 5 THR B 134 ASP B 149 1 16 HELIX 6 6 ASN B 152 GLU B 174 1 23 HELIX 7 7 VAL B 177 HIS B 193 1 17 HELIX 8 8 LEU B 194 ASN B 201 1 8 HELIX 9 9 GLY B 203 GLY B 212 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1